Abstract
Selective androgenic receptor modulators (SARMs) have not been approved by the U.S. Food and Drug Administration but they are heavily promoted as alternatives to androgenic anabolic steroids. We present two cases of liver injury associated with SARMs.
Cite
CITATION STYLE
APA
Flores, J. E., Chitturi, S., & Walker, S. (2020). Drug-Induced Liver Injury by Selective Androgenic Receptor Modulators. Hepatology Communications, 4(3), 450–452. https://doi.org/10.1002/hep4.1456
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free